New injection aims to soothe painful fat lumps
NCT ID NCT06303570
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether CBL-514 injections can reduce pain from lipomas in people with Dercum's disease. Nineteen adults with at least 4 painful lipomas will receive either the drug or a placebo. The main goal is to see if the treatment lowers pain scores.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CBL-514 injection
- What this could lead to
- If it works, this could point toward a non-surgical treatment to ease pain from Dercum's disease lipomas.
- What could go wrong
- This is a very small, early phase 2 study with only 19 people. The results may not apply to everyone, and the treatment might not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERCUM'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigator Site
Spokane, Washington, 99204, United States